Biotechnology is a highly specialised segment within the pharmaceutical space. In recent years
biotechnology has evolved to lead the industry standard in medicines manufacturing by implementing cheaper
and faster processes for producing drugs. Biotechnology has similarly expanded to include new and
diverse sciences and with the advent of biosimilars, these medicines are becoming more accessible for
patients globally. In parallel to this expansion, the concept of biotechnology also encompasses a wide range
The biotech industry in transition faces many challenges, the most fundamental one being how to successfully optimise and scale-up manufacturing processes and achieve successful commercial scale manufacturing. This requires years of experience and in-depth specialised know-how.
This two-day, must-attend, education conference will use case studies to explore current technologies, regulatory requirements and will provide you with techniques for the evaluation and implementation of cutting-edge technologies. In-depth discussion will focus on cost-effective, flexible, sustainable manufacturing facilities design and implementation.
The Programme will include seminars, case studies, workshops and Q&A sessions.
View the Conference Agenda ( 170 KB)
View the Conference Flyer ( 107 KB)
Chair: Dr. David Estapé, Technology Manager Biotech, M+W Germany GmbH, Germany
Co-Chair: Dr. Steven Davy, PhD, Specialist Active Products & Utility, NNE Pharmaplan, Denmark
Miriam Monge, Vice President Sales & Marketing, Biopharm Services Ltd, France
Philippe Robin, Senior Consultant, Pharmacy, Jacobs, France
Bruce Williams, Director, Williams Process Limited, UK
Dave Wolton, Biotechnology Consultant, PM Group, Ireland
Britt Petty, Director MEF, Biogen Idec, Denmark
* Complimentary Guide of Your Choice (electronic download) included with registration
During the afternoon of day one, delegates will have the opportunity to visit a state-of-the-art site to see in action the concepts presented throughout the conference.
(Places are limited for each site and will be allocated on a first-come, first-served basis.)
This conference will be of value to mid- and senior level professionals from the pharmaceutical and biopharmaceutical industry, suppliers and regulators, process development scientists, technology transfer managers, manufacturing managers, engineers, quality assurance professionals, quality control professionals, risk assessment professionals and academia.